Banks, W. A., & Erickson, M. A. (2010). The blood-brain barrier and immune function and dysfunction. Neurobiol Dis, 37(1), 26-32. doi:10.1016/j.nbd.2009.07.031
Bechmann, I., Galea, I., & Perry, V. H. (2007). What is the blood-brain barrier (not)? Trends Immunol, 28(1), 5-11. doi:10.1016/j.it.2006.11.007
Bechter, K. (2013). Updating the mild encephalitis hypothesis of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 42, 71-91. doi:10.1016/j.pnpbp.2012.06.019
Blank T, Detje CN, Spieß A, Hagemeyer N, Brendecke SM, Wolfart J, Staszewski O, Zöller T, Papageorgiou I, Schneider J, Paricio-Montesinos R, Eisel UL, Manahan-Vaughan D, Jansen S, Lienenklaus S, Lu B, Imai Y, Müller M, Goelz SE, Baker DP, Schwaninger M, Kann O, Heikenwalder M, Kalinke U, Prinz M. Brain Endothelial- and Epithelial-Specific Interferon Receptor Chain 1 Drives Virus-Induced Sickness Behavior and Cognitive Impairment. Immunity. 2016 Apr 19;44(4):901-12. doi: 10.1016/j.immuni.2016.04.005.
Cai, H. Q., Catts, V. S., Webster, M. J., Galletly, C., Liu, D., O'Donnell, M., Weickert, T. W., & Weickert, C. S. (2020). Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation. Mol Psychiatry, 25(4), 761-775. doi:10.1038/s41380-018-0235-x
Carvey, P. M., Hendey, B., & Monahan, A. J. (2009). The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. Journal of Neurochemistry, 111(2), 291-314. doi:10.1111/j.1471-4159.2009.06319.x
Deisenhammer, F., Bartos, A., Egg, R., Gilhus, N. E., Giovannoni, G., Rauer, S., & Sellebjerg, F. (2006). Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol, 13(9), 913-922. doi:10.1111/j.1468-1331.2006.01493.x
Endres, D., Meixensberger, S., Dersch, R., Feige, B., Stich, O., Venhoff, N., Matysik, M., Michel, M., Runge, K., Nickel, K., Urbach, H., Domschke, K., Prüss, H., & Tebartz van Elst, L. (2020). Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis. Transl Psychiatry. 10(1):279. doi: 10.1038/s41398-020-00967-3.
Endres, D., Perlov, E., Baumgartner, A., Hottenrott, T., Dersch, R., Stich, O., & Tebartz van Elst, L. (2015). Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients. Front Hum Neurosci, 9, 476. doi:10.3389/fnhum.2015.00476
Kong, D. H., Kim, Y. K., Kim, M. R., Jang, J. H., & Lee, S. (2018). Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. Int J Mol Sci, 19(4). doi:10.3390/ijms19041057
Krönig, H., Riedel, M., Schwarz, M. J., Strassnig, M., Möller, H. J., Ackenheil, M., & Müller, N. (2005). ICAM G241A Polymorphism and Soluble ICAM-1 Serum Levels: Evidence for an Active Immune Process in Schizophrenia. Neuroimmunomodulation, 12(1), 54-59. doi:10.1159/000082364
Kuzior, H., Fiebich, B.L., Yousif, N.M., Saliba, S.W., Ziegler, C., Nickel, K., Maier, S.J., Süß, P., Runge, K., Matysik, M., Dersch, R., Berger, B., Robinson, T., Venhoff, N., Kessler, F., Blank, T., Domschke, K., Tebartz van Elst, L., Endres, D (2020). Increased IL-8 Concentrations in the Cerebrospinal Fluid of Patients with Unipolar Depression. Comprehensive Psychiatry. In press.
Lawson, C., & Wolf, S. (2009). ICAM-1 signaling in endothelial cells. Pharmacol Rep, 61(1), 22-32. doi:10.1016/s1734-1140(09)70004-0
Mantere O, Trontti K, García-González J, Balcells I, Saarnio S, Mäntylä T, Lindgren M, Kieseppä T, Raij T, Honkanen JK, Vaarala O, Hovatta I, Suvisaari J. Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis. J Psychiatr Res. 2019 Feb;109:18-26. doi: 10.1016/j.jpsychires.2018.11.008. Epub 2018 Nov 10.
Muller, N. (2019). The Role of Intercellular Adhesion Molecule-1 in the Pathogenesis of Psychiatric Disorders. Front Pharmacol, 10, 1251. doi:10.3389/fphar.2019.01251
Müller, N., & Bechter, K. (2013). The mild encephalitis concept for psychiatric disorders revisited in the light of current psychoneuroimmunological findings. Neurology Psychiatry and Brain Research, 19. doi:10.1016/j.npbr.2013.04.004
Najjar, S., Pahlajani, S., De Sanctis, V., Stern, J. N. H., Najjar, A., & Chong, D. (2017). Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence. Front Psychiatry, 8, 83. doi:10.3389/fpsyt.2017.00083
Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013). Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation, 10, 142. doi:10.1186/1742-2094-10-142
Nguyen, T. T., Dev, S. I., Chen, G., Liou, S. C., Martin, A. S., Irwin, M. R., Carroll, J. E., Tu, X., Jeste, D. V., & Eyler, L. T. (2018). Abnormal levels of vascular endothelial biomarkers in schizophrenia. Eur Arch Psychiatry Clin Neurosci, 268(8), 849-860. doi:10.1007/s00406-017-0842-6
Orlovska-Waast, S., Köhler-Forsberg, O., Brix, S. W., Nordentoft, M., Kondziella, D., Krogh, J., & Benros, M. E. (2019). Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis. Molecular Psychiatry, 24(6), 869-887. doi:10.1038/s41380-018-0220-4
Pollak, T. A., Drndarski, S., Stone, J. M., David, A. S., McGuire, P., & Joan Abbott, N. (2018). The blood–brain barrier in psychosis. Lancet Psychiatry; 5: 79–92.
Pollak, T.A., Lennox, B.R., Müller, S., Benros ,M.E., Prüss, H., Tebartz van Elst, L., Klein, H., Steiner, J., Frodl, T., Bogerts, B., Tian, L., Groc, L., Hasan, A., Baune, B.T., Endres, D., Haroon, E., Yolken, R., Benedetti, F., Halaris, A., Meyer, J.H., Stassen, H., Leboyer, M., Fuchs, D., Otto, M., Brown, D.A., Vincent, A., Najjar, S., Bechter, K.. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry. 2020 Jan;7(1):93-108. doi: 10.1016/S2215-0366(19)30290-1. Epub 2019 Oct 24.
Radu, G., Luca, C., Petrescu, L., Bordejevic, D. A., Tomescu, M. C., Andor, M., Citu, I., Mavrea, A., Buda, V., Tomescu, C., Borcan, F., & Dehelean, L. (2020). The Predictive Value of Endothelial Inflammatory Markers in the Onset of Schizophrenia. Neuropsychiatr Dis Treat, 16, 545-555. doi:10.2147/ndt.S240349
Ramos, T. N., Bullard, D. C., & Barnum, S. R. (2014). ICAM-1: isoforms and phenotypes. J Immunol, 192(10), 4469-4474. doi:10.4049/jimmunol.1400135
Reiber, H., & Peter, J. B. (2001). Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. 184(2), 101-122. doi:10.1016/s0022-510x(00)00501-3
Reiber, H., & Uhr, M. (2018). Physiologie des Liquors. In P. Berlit (Ed.), Klinische Neurologie (pp. 1-19). Berlin, Heidelberg: Springer Berlin Heidelberg.
Schwarz, M. J., Ackenheil, M., Riedel, M., & Müller, N. (1998). Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia. Neuroscience Letters, 253(3), 201-203. doi:10.1016/s0304-3940(98)00655-7
Schwarz, M. J., Riedel, M., Ackenheil, M., & Müller, N. (2000). Decreased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients. Biological Psychiatry, 47(1), 29-33. doi:10.1016/s0006-3223(99)00206-1
Serlin, Y., Shelef, I., Knyazer, B., & Friedman, A. (2015). Anatomy and physiology of the blood–brain barrier. Seminars in Cell & Developmental Biology, 38, 2-6. doi:10.1016/j.semcdb.2015.01.002
Stefanovic, M. P., Petronijevic, N., Dunjic-Kostic, B., Velimirovic, M., Nikolic, T., Jurisic, V., Lackovic, M., Damjanovic, A., Totic-Poznanovic, S., Jovanovic, A. A., & Ivkovic, M. (2016). Role of sICAM-1 and sVCAM-1 as biomarkers in early and late stages of schizophrenia. J Psychiatr Res, 73, 45-52. doi:10.1016/j.jpsychires.2015.11.002
Stich, O., Andres, T.A., Gross, C.M., Gerber, S.I., Rauer, S., Langosch, J.M. (2015). An observational study of inflammation in the central nervous system in patients with bipolar disorder. Bipolar Disord. 17(3):291-302. doi: 10.1111/bdi.12244. Epub 2014 Aug 11.
Tumani, H., Huss, A., & Bachhuber, F. (2017). The cerebrospinal fluid and barriers - anatomic and physiologic considerations. Handb Clin Neurol, 146, 21-32. doi:10.1016/b978-0-12-804279-3.00002-2
Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017 Feb;60:1-12. doi: 10.1016/j.bbi.2016.03.010. Epub 2016 Mar 16.
Wildemann, B., Oschmann, P., & Reiber, H. (2010). Laboratory diagnosis in neurology (1st edition ed.). Stuttgart: Thieme.
Yousef H, Czupalla CJ, Lee D, Chen MB, Burke AN, Zera KA, Zandstra J, Berber E, Lehallier B, Mathur V, Nair RV, Bonanno LN, Yang AC, Peterson T, Hadeiba H, Merkel T, Körbelin J, Schwaninger M, Buckwalter MS, Quake SR, Butcher EC, Wyss-Coray T. Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1. Nat Med. 2019 Jun;25(6):988-1000. doi: 10.1038/s41591-019-0440-4. Epub 2019 May 13.